673P - Comparison of cytotoxic backbones for first line trastuzumab-containing regimens in HER2-positive advanced esophagogastric cancer: A meta-analysis

Autor: ter Veer, E., Creemers, A., de Waal, L., van Oijen, M.G.H., van Laarhoven, H.W.M.
Zdroj: In Annals of Oncology September 2017 28 Supplement 5:v229-v229
Databáze: ScienceDirect